Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this year.

JointMedica, a global leader in orthopedic innovation, announces the commencement of an Investigational Device Exemption (IDE) study for its Polymotion® Hip Resurfacing (PHR®) device. The IDE study ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

Full REMAIN-1 pivotal study enrollment anticipated in summer 2025 ...

The AeroNova System is a novel, minimally invasive medical device designed to deliver continuous diaphragm neurostimulation in tandem with mechanical ventilation. The investigational device aims to ...

Transformational 2024: successfully advanced from preclinical to clinical stage companyStrengthened leadership team to drive growth and advance ...

The AeroNova System is a novel, minimally invasive medical device designed to deliver continuous diaphragm neurostimulation in tandem with mechanical ventilation. The investigational device aims ...

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...

The investigational AeroNova® System delivers ... (MV), is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) for the ...

Abbott received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy (IVL) system.

a leading neurostimulation company committed to advancing therapies that assist patients in overcoming the negative effects of mechanical ventilation (MV), is excited to announce approval of an ...